◆ FUNDING DATA
- Round
- Series C
- Amount
- $75.0M
- Total raised
- $453.0M
- Location
- Copenhagen, Denmark
- Priority score
- 75/100
- Confidence
- 70/100
Investors
Jeito Capital · Vida Ventures · BPI France · EIFO
Series C⬢ HOT
ADCendo.
Adcendo develops a pipeline of first- and best-in-class antibody-drug conjugates (ADCs) targeting cancers with high unmet medical needs, powered by novel target biology, optimized linker-payload technology, and rational clinical development strategy.